RESULTS AND ADVERSE OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION: HISTORICAL COHORT STUDY

T Rakhypbekov1, G Shalgumbayeva2, Z Siyazbekova2

  • 11 Republican Center for Health Development; Kazakhstan.

Georgian Medical News
|December 3, 2020
PubMed

Insights

This study analyzed percutaneous coronary intervention (PCI) outcomes in Kazakhstan from 2012-2018. In-hospital mortality after PCI was 2.7%, with higher rates in women and older patients.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Percutaneous coronary intervention (PCI) has rapidly advanced in Kazakhstan.
  • Limited data exists on PCI outcomes within the country.

Purpose of the Study:

  • To analyze outcomes of PCI in two regions of Kazakhstan between 2012 and 2018.
  • To identify predictors of in-hospital mortality following PCI.

Main Methods:

  • Registry-based historical cohort study.
  • Analysis of 11,931 patients undergoing PCI in East Kazakhstan and Pavlodar regions.
  • Multivariate logistic regression for in-hospital mortality predictors.

Main Results:

  • Overall in-hospital mortality was 2.7% (320 patients).
  • Higher mortality observed in women, patients aged 70+, and those with cerebral infarction.
  • Independent predictors included age, gender, hospitalization route, and diagnosis.

Conclusions:

  • PCI outcomes in Kazakhstan show a 2.7% in-hospital mortality rate.
  • Specific patient demographics and conditions are associated with increased mortality risk.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
101
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
133
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
589
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
106